News and Trends 22 Aug 2022 Roche launches COVID-19 test to detect emerging variant of interest …of BA.2.75 have been reported in more than a dozen countries. The BA.2.75 is a sub-variant related to the Omicron variant. The sub-variant is being monitored by both the World… August 22, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2022 CanSinoBIO to present latest data on inhaled COVID vaccine …Air induces a strong and lasting immune response, with greater immunogenicity against the Omicron variant than recombinant protein or inactivated vaccines. The neutralizing antibody levels against the Omicron variant with… October 5, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Jan 2025 Singapore’s biotech scene: 7 companies leading the way in 2025 …ancestral strain, one against an Omicron strain, and a bivalent vaccine candidate with components of both ancestral and Omicron strains. Additionally, in March 2023, RVAC announced a research collaboration with… January 14, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 13 Dec 2022 Ascletis announces positive COVID-19 trial results …exciting clinical efficacy against omicron infections in Chinese patients. Based on the company’s phase I results of ASC10 and molnupiravir’s clinical efficacy data in American, Japanese and Chinese patients, 800… December 13, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jun 2022 US Toddlers and children to receive Covid-19 vaccine after emergency approval granted …immunogenicity data, administered in a 3-dose series, provides young children and infants with a high level of protection, also during the recent Omicron wave.” Predominant variant Pfizer said the authorization… June 22, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Oct 2025 Six companies leading the mRNA revolution in biotechnology …is successfully entrapped into a vector. The focus of its pipeline is on cancer, infectious diseases, and rare diseases. Its mRNA-based COVID-19 vaccine targeting SARS-2-COV-2 Omicron is in phase 3… October 7, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2022 Beyond Biotech podcast 21: CanSinoBIO, HTID, Longevity Science Foundation …Barcelona, Spain. Jean-Denis Shu, vice president for medical affairs of CanSino Biologics showed Convidecia Air induces a strong and lasting immune response, with greater immunogenicity against the Omicron variant than… November 4, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Nov 2023 Eight biotech companies tackling infectious diseases head-on …year, BioNTech, along with pharma giant Pfizer, was granted emergency use authorization for its Omicron XBB.1.5-adapted monovalent COVID-19 vaccine for patients aged six months and older, by the FDA. This… November 7, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2022 Immorna cleared for mRNA-based Covid-19 vaccine study …their immunogenicity. In preclinical testing, JCXH-221 elicited robust neutralizing antibodies against an assay of viral strains, including the ancestral, Beta, Delta, Omicron BA.1, BA.2.12.1, and BA.4/5. JCXH-221 is formulated with… November 21, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 Sanofi and GSK Covid-19 booster vaccine approved by European Commission …public health as the pandemic evolves further.” In registration studies, carried out at times when Omicron strains were predominantly circulating, the vaccine induced a strong immune response against multiple variants…. November 10, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 23 Nov 2022 Tevogen Bio to investigate T cell therapy in long Covid …adverse events. Patients treated were infected with a range of all Covid variants at the time, from Delta through Omicron BA.5. Additionally, each patient had co-morbidities rendering them high risk… November 23, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2022 Startup USSF bringing oral COVID vaccine to market …past 12 months were exposed to the delta and omicron (BA.5) with BQ.1/BQ1.11 appearing at the tail end of the study. In our recent clinical trial, fewer people contracted COVID… December 14, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email